dec@administration@reasonable@dose-response-relationship-immunologic@numbers@brandt-c-d@three@professionally@years@support-u-s-govt-p-h-s@institution@split@children@recruitment@safety@titers@orthomyxovirus-type-a-human@titer@greater@a/new@hswn1@england@likely@zh mikrobio epidemio immunobi 1982@antibody@vasilyeva@im@ae@hssn1@monovalent@j-infect-dis@kim-h-w@child-preschool@insufficient@received@significant@s588-91@patient-care-team@dose@volunteer@involved@bivalent@ri@adolescence@chanock-r-m@a/victoria/75@washington@continuing@child@care@influenza@suppl@systemic@study@doses@vaccines@inactivated@bi@a/nj/76@virus@two@hemagglutination-inhibiting@d.c@and/or@studies@cystic-fibrosis@human@close@arrobio-j-o@antigenicity@normal@new-jersey@occurred@jersey/nj/76@studied@knew@aged@jersey/76@team@antibodies-viral@families@hemagglutination-inhibition-tests@district-of-columbia@split-virus@equal@vaccine@trials@pd@whole-virus@unfamiliar@responses@achieved@reactions@parrott-r-h@age@influenza-vaccine@